通过甲基胺暂时抑制多巴胺载体棕化:对运输法规的影响
bioRxiv : the preprint server for biology
|July 14, 2025
概括
甲基胺 (METH) 迅速降低多巴胺载体 (DAT) 棕化,这是一个关键的修改. 这种减少与METH诱导的DAT下调有关,这表明棕化调节载体功能.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 多巴胺转运体 (DAT) 通过多巴胺 (DA) 再吸收来调节多巴胺能神经传递.
- 通过翻译后的修改来调节DAT功能,包括棕化,从而增强运输.
- DAT的失调与情绪障碍和药物成有关.
研究的目的:
- 为了研究甲基胺 (METH) 对DAT棕化反应的影响.
- 确定DAT棕化和METH诱导的下调之间的机制联系.
- 探讨棕细胞代谢在调节DAT活动中的作用.
主要方法:
- 在老鼠的条纹体和异质细胞中进行的实验.
- 对DAT棕化水平对METH暴露的反应进行分析.
- 利用一种棕代谢缺陷的DAT突变来评估功能后果.
主要成果:
- 甲基胺 (METH) 导致DAT棕化中的快速和短暂的减少.
- 棕化降低的时间过程与METH诱导的DAT下调平行.
- 一种棕化缺陷的DAT突变体在对METH的反应中表现出增强的下调调节.
结论:
- 棕化作为快速反应机制,调节DAT进入METH诱导的下调.
- 减少棕化与在METH暴露后降低DAT再吸收活性有机联系.
- 棕化可能在控制各种生理和病理生理状态下的DAT再吸收方面发挥更广泛的作用.
相关概念视频
Drugs Affecting Neurotransmitter Synthesis
1.6K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.6K
Adrenergic Agonists: Indirect-Acting Agents
1.9K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.9K
Desensitization and Tachyphylaxis
2.2K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.2K
Drugs Affecting Neurotransmitter Release or Uptake
1.2K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.2K
Neurochemical Transmission: Sites of Drug Action
2.7K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.7K
Drug Abuse and Addiction: Pharmacological Phenomena
659
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
659


